本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

30.22
+0.45001.51%
成交量:70.22万
成交额:2,127.32万
市值:22.05亿
市盈率:-128.24
高:30.69
开:29.84
低:29.70
收:29.77
数据加载中...
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/09

SEC问询函

Form CORRESP - Correspondence
2023/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

SEC问询函

Form CORRESP - Correspondence
2023/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/31

重要事件披露

Form 8-K - Current report
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/18

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/25

重要事件披露

Form 8-K - Current report
2023/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/07

重要事件披露

Form 8-K - Current report
2023/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]